GlassScriptPhysician profile
Aubrey Mcbryde
NPI 1356399174
$1,321.65
in general payments reported to CMS, 2019-2025
21 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $329 · 2023: $262 · 2024: $184 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $271.79 | 2022-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $118.69 | 2022-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $107.17 | 2021-2025 | |
| Glaxosmithkline, LLC. | $105.47 | 2021-2025 | Bexsero, Pediarix, Penmenvy |
| Corium, LLC | $102.54 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $90.40 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $79.63 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sobi, INC | $65.66 | 2022-2023 | |
| Tris Pharma INC | $60.19 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $50.80 | 2021-2024 | Crysvita |
| Collegium Pharmaceutical, INC. | $49.93 | 2025 | Jornay Pm |
| Pfizer INC. | $32.96 | 2021-2023 | |
| Baxter Healthcare | $31.35 | 2025 | Hillrom - Monarch Airway Clearance System |
| Mirum Pharmaceuticals, INC. | $28.76 | 2023 | Livmarli |
| Kyowa Kirin, INC. | $25.11 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $22.53 | 2025 | Neffy |
| Genzyme Corporation | $19.09 | 2022 | |
| Biogen, INC. | $16.99 | 2021 | |
| Ossur Americas, INC. | $15.28 | 2024 | |
| Alexion Pharmaceuticals, INC. | $15.21 | 2025 | Koselugo |
| Seqirus USA INC | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrey Mcbryde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.